Adult-onset expression of Hsap\MAPTScer\UAS.2N4R.wt (two copies) driven by Scer\GAL4elav.Switch.PO (feeding adult flies RU486) leads to a significantly shorter lifespan compared to controls at 29[o]C; driving a single copy of Hsap\MAPTScer\UAS.2N4R.wt at 29[o]C (but not 25[o]C) also significantly reduces lifespan but to a lesser degree. Flies with adult-onset (feeding adult flies RU486) expression of Hsap\MAPTScer\UAS.2N4R.wt driven by Scer\GAL4elav.Switch.PO have significant locomotor (climbing ability) defects at 10 and even more so at 15 days old, and show progressive loss of rhabdomeres (around 15% of ommatidia lack at least one rhabdomere by day 27) compared to controls.
Flies with adult-onset (feeding adult flies RU486) expression of Hsap\MAPTK280Q.Scer\UAS.2N4R driven by Scer\GAL4elav.Switch.PO show progressive loss of rhabdomeres (around 30% of ommatidia lack at least one rhabdomere by day 27 and degeneration is detectable already at day 9), significantly more degeneration than is seen with expression of Hsap\MAPTScer\UAS.2N4R.wt or Hsap\MAPTK280R.Scer\UAS.2N4R (expression of either of these lines leads to similar amounts of progressive rhabdomere loss).
Clearance of Hsap\MAPT (2 days of RU486 feeding to induce expression followed by 2 to 5 days without RU486) is significantly slower with expression of Hsap\MAPTK280Q.Scer\UAS.2N4R driven by Scer\GAL4elav.Switch.PO, compared to expression of Hsap\MAPTScer\UAS.2N4R.wt or Hsap\MAPTK280R.Scer\UAS.2N4R.
Locomotor defects (at 13 days old) are significantly less severe in flies with expression of Hsap\MAPTK280R.Scer\UAS.2N4R compared to expression of Hsap\MAPTK280Q.Scer\UAS.2N4R or Hsap\MAPTScer\UAS.2N4R.wt (driven by Scer\GAL4elav.Switch.PO, with RU486 feeding of adults).
Lifespan is significantly shorter in flies with expression of Hsap\MAPTScer\UAS.2N4R.wt driven by Scer\GAL4elav.Switch.PO (with RU486 feeding of adults), compared to controls.